Abnormal cysts in postmenopausal women usually require surgical evaluation
According to a Bloomberg investigation published Monday, a blind spot in Food and Drug Administration (FDA) regulations that allows pharmacies and compounders to reproduce drugs that are in short supply has helped to create a market of unbranded weight-loss drugs worth $1bn annually
People tracking their tirzepatide before and after progress consistently report more dramatic transformations than those on older GLP-1 medications
Storage, handling, and practical considerations The day-to-day logistics of using these medications involve more than just injecting
In studies, the average long-term weight loss with Wegovy was 35 to 39 lbs (16 to 17.7 kg) and about 21% of body weight with Wegovy HD
The study did not explain why lean body mass loss was greater with tirzepatide, which mimics GLP-1 and GIP, than with semaglutide, which only mimics GLP-1, although both slow digestion and make patients feel full, Reuters reported